Uncategorized
Liquid biopsy: The future of minimal residual disease detection?
Written by Victoria Simms, March 16, 2022. reviewed by Celina Whalley, April 26 2024. Detection of minimal residual disease Minimal residual disease (MRD) is defined as a very small number of cancer cells that remain in the body during or after treatment.1 This may be locally at the site of surgery, distant at metastatic sites…
Read MoreLiquid biopsies: epigenetic clues for early cancer detection
Written November 17, 2021. Reviewed by Celina Whalley April 26, 2024 Current screening limitations Cancer is a leading cause of morbidity and mortality globally. Despite early diagnosis and treatment being one of the most effective methods to improve outcomes for cancer patients, early detection remains challenging. Screening methods are available for some tumor types, such…
Read MoreTracking the evolution of SARS CoV-2 using whole genome sequencing (WGS)
November 3, 2021. Reviewed by Victoria Simms, April 23, 2024. Why monitoring the evolution of the virus is crucial to public health Viral genome sequencing: the background story Rapid whole viral genome sequencing, decoding a pathogen’s entire genome, is essential to public health organizations and epidemiologists for tracking and surveillance of disease outbreaks. Genomic epidemiologists around the…
Read More